151 related articles for article (PubMed ID: 28677763)
1. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1.
Zhou Y; Ji Z; Yan W; Zhou Z; Li H; Xiao Y
Oncol Rep; 2017 Aug; 38(2):837-842. PubMed ID: 28677763
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.
Yu J; Wang X; Li Y; Tang B
Oncol Rep; 2017 Mar; 37(3):1394-1400. PubMed ID: 28184921
[TBL] [Abstract][Full Text] [Related]
3. Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway.
Zhou Y; Zhou Z; Ji Z; Yan W; Li H; Yu X
Int J Oncol; 2020 Jul; 57(1):314-324. PubMed ID: 32319592
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
Pan H; Zhu Y; Wei W; Shao S; Rui X
World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
[TBL] [Abstract][Full Text] [Related]
5. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
Wang W; Guo Z; Yu H; Fan L
J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
[TBL] [Abstract][Full Text] [Related]
6. Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion.
Li Y; Ligr M; McCarron JP; Daniels G; Zhang D; Zhao X; Ye F; Wang J; Liu X; Osman I; Mencher SK; Lepor H; Wang LG; Ferrari A; Lee P
Clin Cancer Res; 2011 Jul; 17(13):4414-24. PubMed ID: 21606178
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
9. FOXM1-mediated downregulation of uPA and MMP9 by 3,3'-diindolylmethane inhibits migration and invasion of human colorectal cancer cells.
Jin H; Li XJ; Park MH; Kim SM
Oncol Rep; 2015 Jun; 33(6):3171-7. PubMed ID: 25962429
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
[TBL] [Abstract][Full Text] [Related]
11. Treatment with docetaxel in combination with Aneustat leads to potent inhibition of metastasis in a patient-derived xenograft model of advanced prostate cancer.
Qu S; Ci X; Xue H; Dong X; Hao J; Lin D; Clermont PL; Wu R; Collins CC; Gout PW; Wang Y
Br J Cancer; 2018 Mar; 118(6):802-812. PubMed ID: 29381682
[TBL] [Abstract][Full Text] [Related]
12. CSN5 promotes the invasion and metastasis of pancreatic cancer by stabilization of FOXM1.
Mao L; Le S; Jin X; Liu G; Chen J; Hu J
Exp Cell Res; 2019 Jan; 374(2):274-281. PubMed ID: 30352219
[TBL] [Abstract][Full Text] [Related]
13. [Role of inhibition of transcription factor forkhead box M1 expression by RNA interference in the proliferation and invasiveness of non-small cell lung cancer cells].
Zhou L; Zhang PH; Xu X; Xu N; Gao L; Bai CX; Zhang X
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2424-8. PubMed ID: 20137699
[TBL] [Abstract][Full Text] [Related]
14. [Forkhead domain inhibitor-6 (FDI-6) increases apoptosis and inhibits invasion and migration of laryngeal carcinoma cells by down-regulating nuclear FoxM1].
Liu Y; Zhu L; Wen T; Wan J; Lei Y; Chen H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):611-616. PubMed ID: 28502298
[TBL] [Abstract][Full Text] [Related]
15. Tetramethylpyrazine inhibits tumor growth of lung cancer through disrupting angiogenesis via BMP/Smad/Id-1 signaling.
Jia Y; Wang Z; Zang A; Jiao S; Chen S; Fu Y
Int J Oncol; 2016 May; 48(5):2079-86. PubMed ID: 26984046
[TBL] [Abstract][Full Text] [Related]
16. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression.
Bi Z; Liu W; Ding R; Wu Y; Dou R; Zhang W; Yuan X; Liu X; Xiong L; Guo Z; Mao C
Eur J Pharmacol; 2017 Feb; 796():175-189. PubMed ID: 28012972
[TBL] [Abstract][Full Text] [Related]
17. Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
Wang X; Niu Z; Jia Y; Cui M; Han L; Zhang Y; Liu Z; Bi D; Liu S
Oncol Rep; 2016 Apr; 35(4):2121-30. PubMed ID: 26846372
[TBL] [Abstract][Full Text] [Related]
18. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor.
Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K
Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373
[TBL] [Abstract][Full Text] [Related]
19. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).
Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J
Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698
[TBL] [Abstract][Full Text] [Related]
20. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
